FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

The US FDA approved Vertex Pharmaceuticals’ Journavx, a new pain pill designed to reduce addiction and overdose risks associated with opioids, offering an alternative for short-term pain relief post-surgery or injuries. The drug, priced at $15.50 per pill, works by blocking pain-signaling proteins rather than targeting brain receptors like opioids, showing promise despite modest effectiveness and some side effects. While Vertex faces challenges with its chronic pain drug pipeline, they plan to proceed with further studies to potentially address the opioid crisis.

Full Article